Tumor Binding and Therapeutic Efficacy of 213-Bi Labeled Mutation Specific Monoclonal Antobody in a Human Intraperitoneal Gastric Cancer Model.
Abstract not available
SENEKOWITSCH-SCHMIDTKE R.;
FISCHER K.;
SCHUMACHER C.;
BECKER I.;
BECKER K.;
APOSTOLIDIS Christos;
NIKULA T.;
SCHWAIGER M.;
2001-02-09
JRC21180
https://publications.jrc.ec.europa.eu/repository/handle/JRC21180,
Additional supporting files
| File name | Description | File type | |
|---|
